Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Clinical trial NCT01049945 · COMPLETED

Trial details

NCT number: NCT01049945
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Multiple Myeloma

Start date: 2010-02-01
Primary completion: 2012-11-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.